Shah Gilani's Archive
Shah Gilani
Wall Street superstar and former hedge fund manager Shah Gilani is the Chief Investment Strategist of Manward Press and at the helm of the Manward Money Report newsletter and the Launch Investor and Alpha Money Flow trading services. He’s a sought-after market commentator and has appeared on CNBC, Fox Business and Bloomberg TV. He’s also been quoted in The Wall Street Journal, The New York Times and The Washington Post, and he’s had columns published in Forbes.
In 1982, he launched his first hedge fund from his seat on the floor of the Chicago Board Options Exchange. He worked in the pit as a market maker when options on the S&P 100 Index first began trading… and was part of a handful of traders who laid the technical groundwork for what would eventually become the CBOE Volatility Index (VIX). He also ran the futures and options division at the largest retail bank in Britain. Shah gained notoriety for calling the implosion of U.S. financial markets (all the way back in February 2008) AND the mega bull run that followed.
Now at the helm of Manward, Shah is focused tightly on one goal: To do his part to make subscribers wealthier, happier and more free.
Monday Takeaways: Sentiment Has Turned… Get Ready to Buy
The Fed’s promise of a rate cut did nothing to calm nerves after a poor job report. Here’s what’s coming…
The Tech Sector Selloff Is All About the Money
The initial AI boom has given way to a more nuanced – and potentially concerning – secondary narrative. Here’s what investors need to know…
Buy This, Not That: Looking for Fertile Profits With These 6 Ag Stocks
The agriculture sector grows and wilts by the changing of the seasons… the weather… and supply/demand. But what about the companies that support the ag business worldwide?
Monday Takeaways: The Number to Watch This Week
Was last week’s late stage rally a sign of things to come… these crucial numbers have the answer.
What’s Really Behind the Surge in Small Caps
After posting quick double-digit gains… the Russell 2000 is begging for a closer look. The truth is… this extraordinary performance raises key questions…
Buy This, Not That: A Big Dose of 5 Big Pharma Stocks
Which of these five drugmakers stocks hands out a prescription for portfolio health?
Monday Takeaways: A Perfect Storm of Politics, Earnings, and Economic Data
Tech stocks took a beating last week… the markets jumped in early Monday trading… and some big data awaits. Here’s what’s affecting your money this week…
This Weakening Sector Says There’s Danger Ahead
Bank earnings are out… and they have an interesting tale to tell. There’s good news and bad news… and signs there could be challenges ahead.
Buy This, Not That: Are the Big Banks Big Buys?
While the big banks are touting impressive headline numbers, with record highs and substantial profit increases, there’s something lurking under the surface…
Monday Takeaways: Bank on Trouble Coming
Forget the back-to-back-to-back market highs. The latest bank earnings reports are a warning…